141 related articles for article (PubMed ID: 37907630)
1. IL-1R8 expression in DLBCL regulates NK cell recruitment and influences patient prognosis.
Yu M; Zhang Q; Wan L; Wang S; Zou L; Chen Z; Li F
Funct Integr Genomics; 2023 Nov; 23(4):328. PubMed ID: 37907630
[TBL] [Abstract][Full Text] [Related]
2.
Riva F; Filipe J; Fanelli A; Marconato L; Inglesi A; Scanziani E; Soldati S; Licenziato L; Comazzi S; Minoli L; Aresu L
Vet Sci; 2022 Apr; 9(5):. PubMed ID: 35622737
[TBL] [Abstract][Full Text] [Related]
3. IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells.
Landolina N; Mariotti FR; Ingegnere T; Alicata C; Ricci B; Pelosi A; Veneziani I; Azzarone BG; Garlanda C; Mantovani A; Moretta L; Maggi E
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35292515
[TBL] [Abstract][Full Text] [Related]
4. The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor response.
Landolina N; Mariotti FR; Pelosi A; D'Oria V; Ingegnere T; Alicata C; Vacca P; Moretta L; Maggi E
Oncoimmunology; 2024; 13(1):2297504. PubMed ID: 38170019
[TBL] [Abstract][Full Text] [Related]
5. High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity.
Campesato LF; Silva APM; Cordeiro L; Correa BR; Navarro FCP; Zanin RF; Marçola M; Inoue LT; Duarte ML; Molgora M; Pasqualini F; Massara M; Galante P; Barroso-Sousa R; Polentarutti N; Riva F; Costa ET; Mantovani A; Garlanda C; Camargo AA
Oncotarget; 2017 Jul; 8(30):49470-49483. PubMed ID: 28533483
[TBL] [Abstract][Full Text] [Related]
6. Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas.
Sarosiek KA; Malumbres R; Nechushtan H; Gentles AJ; Avisar E; Lossos IS
Blood; 2010 Jan; 115(3):570-80. PubMed ID: 19965678
[TBL] [Abstract][Full Text] [Related]
7. Modulation the expression of natural killer cell activating receptor (NKp44) in the peripheral blood of diffuse large B-cell lymphoma patients and the correlation with clinic pathological features.
Essa ES; Tawfeek GA; El Hassanin SA; Emara KGM
Clin Immunol; 2018 Mar; 188():38-44. PubMed ID: 29247708
[TBL] [Abstract][Full Text] [Related]
8. Expression of Tryptophan Metabolism Enzymes in Patients with Diffuse Large B-cell Lymphoma and NK/T-cell Lymphoma.
Guo D; Wang Y; Wu X; Gao Y; Wang A; Zhang Z; Zhao K; Wang X; Liu M; Zhang Y; Li M; Chen R; Sun J; Zhang Y
Cancer Med; 2023 Jun; 12(11):12139-12148. PubMed ID: 37148546
[TBL] [Abstract][Full Text] [Related]
9. IL-21 Stimulates the expression and activation of cell cycle regulators and promotes cell proliferation in EBV-positive diffuse large B cell lymphoma.
Wang Y; Wang C; Cai X; Mou C; Cui X; Zhang Y; Ge F; Dong H; Hao Y; Cai L; Wu S; Feng C; Chen J; Li J; Xu W; Fan L; Xie W; Tong Y; Gu HF; Wu L
Sci Rep; 2020 Jul; 10(1):12326. PubMed ID: 32704112
[TBL] [Abstract][Full Text] [Related]
10. β-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway.
Hu T; Gao Y
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010942
[TBL] [Abstract][Full Text] [Related]
11. IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC.
Mariotti FR; Supino D; Landolina N; Garlanda C; Mantovani A; Moretta L; Maggi E
Semin Immunol; 2023 Mar; 66():101712. PubMed ID: 36753974
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.
Xie M; Huang X; Ye X; Qian W
Int Immunopharmacol; 2019 Dec; 77():105999. PubMed ID: 31704289
[TBL] [Abstract][Full Text] [Related]
13. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count.
Li YL; Shi ZH; Wang X; Gu KS; Zhai ZM
BMC Cancer; 2019 Nov; 19(1):1049. PubMed ID: 31694577
[TBL] [Abstract][Full Text] [Related]
15. Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.
Ling HY; Yang Z; Wang PJ; Sun Y; Ju SG; Li J; Fu JX
Chem Biol Interact; 2022 Jan; 352():109779. PubMed ID: 34922904
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
17. FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.
Wong KK; Gascoyne DM; Soilleux EJ; Lyne L; Spearman H; Roncador G; Pedersen LM; Møller MB; Green TM; Banham AH
Oncotarget; 2016 Aug; 7(33):52940-52956. PubMed ID: 27224915
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy.
Klanova M; Oestergaard MZ; Trněný M; Hiddemann W; Marcus R; Sehn LH; Vitolo U; Bazeos A; Goede V; Zeuner H; Knapp A; Sahin D; Spielewoy N; Bolen CR; Cardona A; Klein C; Venstrom JM; Nielsen T; Fingerle-Rowson G
Clin Cancer Res; 2019 Aug; 25(15):4634-4643. PubMed ID: 31053601
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic analysis reveals that IL-1R8/Sigirr is a novel macrophage migration regulator and suppresses macrophage proliferation through p38 MAPK signaling pathway.
Guo J; Zhan X; Xu G; Mao C; Wei R
Biomed Pharmacother; 2020 Apr; 124():109846. PubMed ID: 31978769
[TBL] [Abstract][Full Text] [Related]
20. High PTX3 expression is associated with a poor prognosis in diffuse large B-cell lymphoma.
Carreras J; Kikuti YY; Hiraiwa S; Miyaoka M; Tomita S; Ikoma H; Ito A; Kondo Y; Itoh J; Roncador G; Martinez A; Colomo L; Hamoudi R; Ando K; Nakamura N
Cancer Sci; 2022 Jan; 113(1):334-348. PubMed ID: 34706126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
